RADX
Radiopharm Theranostics Limited American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Radiopharm Theranostics (RADX) Stock: Buy, Sell, or Hold?
$0.63
-0.04 (-6.33%)
▼
5d:
-17.05%
30d:
-33.64%
90d:
-74.16%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Feb 26, 2026
Updated Nov 20, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
39/100
Position
OVERSOLD
30-Day Fair Range
$0.77 – $1.04
Position: OVERSOLD
Forward P/E & Valuation
-0.2x
Next 12M consensus est.
Wall Street Target
$16.29
+2484.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.63 / $0.96
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: RADX is down 17.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When RADX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: RADX is currently trading at $0.63, which is considered oversold relative to its 30-day fair value range of $0.77 to $1.04.
Technical Outlook: Technically, RADX is in a strong downtrend. The price is currently testing key support at $0.63. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: RADX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $16.29 (+2484.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RADX is in a strong downtrend. The price is currently testing key support at $0.63. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: RADX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $16.29 (+2484.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.77 -
$1.04
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$0.77 -
$1.04
Current vs Trading Range
OVERSOLD
Support Level
$0.63
Resistance Level
$0.96
Current Trend
Strong Downtrend
Technical data as of
Nov 20, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.3%)
- BULLISH: Trading 2484.6% below Wall St target ($16.29)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.20
Wall Street Target
$16.29
(+2484.6%)
Revenue Growth (YoY)
-36.9%
Share RADX Analysis
Share this live RADX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 22, 2026 5:21 AM ET
Data refreshes hourly during market hours. Next update: 6:21 AM
Data refreshes hourly during market hours. Next update: 6:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RADX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$69 | 65 BUY |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$275 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 38 SELL |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 53 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RADX Research Pages
RADX Technical Chart
RADX Price Prediction
RADX Intrinsic Value DCF
RADX Earnings Date
RADX Investment Advisor
RADX Fair Price Analyzer
RADX Target Price Playground
RADX 5-Day Options Simulator
RADX LEAP Simulator
RADX Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
RADX Competitors
Part B: Tradestie Flagship Market Scanners